Novartis, “We made payments, but never understood what RTM for”

While people are paying interests in whether Novartis shared information internally, it was hard to check clear facts even at examination of a witness from its anticancer department, a key department of the case.

This is because the witness accepted that the company paid the advertising expenses, but he answered that he did not know the advertising expenses were used as a passage to indirectly...